期刊文献+

丁二酸洛沙平与利培酮治疗精神分裂症的疗效比较 被引量:1

下载PDF
导出
摘要 目的:研究丁二酸洛沙平与利培酮治疗精神分裂症的临床疗效与安全性。方法:134例精神分裂症患者随机分成两组,分别给予丁二酸洛沙平与利培酮8周,应用PANSS量表和TESS量表分别评价临床疗效和不良反应。结果:两组之间疗效无显著差异,丁二酸洛沙平起效快,其常见副反应为锥体外系反应(EPS)。结论:丁二酸洛沙平是一种安全、有效、起效快的抗精神病药物。
出处 《内蒙古中医药》 2008年第2X期18-18,共1页 Inner Mongolia Journal of Traditional Chinese Medicine
  • 相关文献

参考文献2

二级参考文献32

  • 1[1]Kapur S, Zipursky RB, Jones C, et al. The D2 receptor occupancy profile of loxapine determined using PET. Neuropsychopharmacology.1996 Dec; 15(6): 562~566
  • 2[2]Roth BL, Craigo SC, Choudhary MS, et al. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther 1994 Mar;268(3) :1403~1410
  • 3[3]Singh AN, Barlas C, Singh S, et al. A neurochemieal basis for the antipsychotie activity of loxapine: interactions with dopamine D1, D2 ,D4 and serotonin 5-HT2 receptor subtypes. J Psychiatry-Neurosci.1996 Jan; 21(1): 29~35
  • 4[4]Kapur S, Zipursky R, Remington G, et al. PET evidence that loxapine is an equipotent blocker of 5-HT2 and D2 receptors: implications for the therapeutics of schizophrenia. Am J Psychiatry. 1997 Nov;154(11): 1525~1529
  • 5[5]William M, Glazer MD. Dose loxapine have "Atypical" properties?clinical evidence. J C lin Psychiatry. 1999 ;60 (supple 10): 42~46
  • 6[6]Peter F, Buckley, MD. The role of typical and atypical antipsychotics medication in the management of agitation and aggression. J Clin Psychiatry. 1999 ;60(supple 10): 52~60
  • 7[7]Meltzer HY, Jayathilake K. Low-dose loxapine in the treatment of schizophrenia: is it more effective and more "atypical" than standard - dose loxapine? J Clin Psychiatry. 1999; 60 Suppl 10: 47~51
  • 8[9]Ereshefsky L. Pharmacologic and pharmacokinetic considerations in choosing an antipsychotic. J Clin Psychiatry. 1999; 60 Suppl 10: 20~30
  • 9Sholevar EH, Baron DA, Hardie TL.Treatment of childhood-onset schizophrenia with olanzapine. J Child Adolesc Psychopharmacol, 2000, 10:69-78.
  • 10Bhana N, Foster RH, Olney R, et al. Olanzapine: an updated review of its use in the management of schizophrenia. Drugs, 2001,61:111-161.

共引文献33

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部